Oseltamivir News and Research

RSS
WHO investigates cases of H1N1 drug resistance in U.S., Britain

WHO investigates cases of H1N1 drug resistance in U.S., Britain

New FluCide better than the older version

New FluCide better than the older version

Adamas Pharmaceuticals expands its Phase 2 TCAD therapy study for influenza A

Adamas Pharmaceuticals expands its Phase 2 TCAD therapy study for influenza A

HHS announces contract awards for up to 120,000 treatment courses of intravenous antiviral drugs

HHS announces contract awards for up to 120,000 treatment courses of intravenous antiviral drugs

TGen to secure emergency FDA approval for 2009 H1N1 flu test

TGen to secure emergency FDA approval for 2009 H1N1 flu test

Drug-cocktail approach offers hope in developing single agent to treat drug-resistant H1N1 swine flu

Drug-cocktail approach offers hope in developing single agent to treat drug-resistant H1N1 swine flu

Web site marketing fraudulent H1N1 flu supplements warned by the FDA and the FTC

Web site marketing fraudulent H1N1 flu supplements warned by the FDA and the FTC

FDA urges consumers to exercise care on online H1N1 drug products

FDA urges consumers to exercise care on online H1N1 drug products

H1N1 illness in young Mexican patients associated with severe acute respiratory distress syndrome

H1N1 illness in young Mexican patients associated with severe acute respiratory distress syndrome

Nanoviricides and Southern Research sign agreement to test anti-Influenza and anti-HIV drug candidates

Nanoviricides and Southern Research sign agreement to test anti-Influenza and anti-HIV drug candidates

FluCide more effective than Tamiflu

FluCide more effective than Tamiflu

Influenza patients treated with Tamiflu has higher survival rates

Influenza patients treated with Tamiflu has higher survival rates

TCAD therapy shows potency against seasonal and novel H1N1 influenza viruses

TCAD therapy shows potency against seasonal and novel H1N1 influenza viruses

New Influenza A/H1N1 detection kit launched

New Influenza A/H1N1 detection kit launched

Members of Blue Shield of California to receive administrative costs of the H1N1 virus vaccine

Members of Blue Shield of California to receive administrative costs of the H1N1 virus vaccine

Phase III trials for CS-8958 neuraminidase inhibitor successful

Phase III trials for CS-8958 neuraminidase inhibitor successful

ViraCor-IBT Laboratories launches new influenza and respiratory virus testing service

ViraCor-IBT Laboratories launches new influenza and respiratory virus testing service

Adamas Pharmaceuticals forges agreement with U.S. Naval Health Research Center for evaluating triple combination antiviral drug

Adamas Pharmaceuticals forges agreement with U.S. Naval Health Research Center for evaluating triple combination antiviral drug

George Rehm and David Mahoney joins Adamas' Board of Directors

George Rehm and David Mahoney joins Adamas' Board of Directors

Tamiflu-resistant swine flu identified along Texas-Mexico border

Tamiflu-resistant swine flu identified along Texas-Mexico border